Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases.

ABSTRACT:

Introduction

Despite recent advances in drug development, durable complete remissions with systemic therapy alone for metastatic cancers remain infrequent. With the development of advanced radiation technologies capable of selectively sparing normal tissues, patients with oligometastases are often amenable to comprehensive involved site radiotherapy with curative intent. This study reports the long-term outcomes and patterns of failure for patients treated with total metastatic ablation often in combination with systemic therapy.

Materials and methods

Consecutive adult patients with oligometastases from solid tumor malignancy treated by a single high volume radiation oncologist between 2014 and 2021 were retrospectively analyzed. Oligometastases were defined as 5 or fewer me

SUBMITTER: Kao J 

PROVIDER: S-EPMC10739409 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature